# NETSTREIT Corp.: financial statements, quarterly

NTST · NYSE · CIK 1798100 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ntst.md) · [Financials](/companies/ntst/financials.md) · [Filings](/companies/ntst/filings.md) · [Insiders](/companies/ntst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ntst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.9 d](/filings/0001628280-26-006901.md) | [37.7](/filings/0001798100-25-000077.md) | [39.6](/filings/0001798100-25-000096.md) | [41.4](/filings/0001628280-25-046456.md) | [44.1 d](/filings/0001628280-26-006901.md) | [45.9](/filings/0001628280-26-026040.md) | [48.3](/filings/0001628280-26-049220.md) | [48.3](/filings/0001628280-26-066726.md) | [52.5 d](/filings/0001628280-26-006901.md) | [57.1](/filings/0001628280-26-026040.md) | [61.3](/filings/0001628280-26-049220.md) | [66.3](/filings/0001628280-26-066726.md) |
| Interest expense | $m | [5.6 d](/filings/0001798100-24-000011.md) | [6.2](/filings/0001798100-24-000058.md) | [7.6](/filings/0001798100-25-000096.md) | [8.0](/filings/0001628280-25-046456.md) | [8.6 d](/filings/0001628280-26-006901.md) | [11.5](/filings/0001628280-26-026040.md) | [12.6](/filings/0001628280-26-049220.md) | [12.6](/filings/0001628280-26-066726.md) | [14.6 d](/filings/0001628280-26-006901.md) | [14.3](/filings/0001628280-26-026040.md) | [15.6](/filings/0001628280-26-049220.md) | [17.7](/filings/0001628280-26-066726.md) |
| Income tax | $m | [0.0 d](/filings/0001628280-26-006901.md) | [0.0](/filings/0001798100-25-000077.md) | [0.0](/filings/0001798100-25-000096.md) | [0.0](/filings/0001628280-25-046456.md) | [0.0 d](/filings/0001628280-26-006901.md) | [0.0](/filings/0001628280-26-026040.md) | [0.0](/filings/0001628280-26-049220.md) | [0.0](/filings/0001628280-26-066726.md) | [0.0 d](/filings/0001628280-26-006901.md) | [0.0](/filings/0001628280-26-026040.md) | [0.1](/filings/0001628280-26-049220.md) | [0.1](/filings/0001628280-26-066726.md) |
| Net income | $m | [2.0 d](/filings/0001628280-26-006901.md) | [1.0](/filings/0001798100-25-000077.md) | [(2.3)](/filings/0001798100-25-000096.md) | [(5.3)](/filings/0001628280-25-046456.md) | [(5.5) d](/filings/0001628280-26-006901.md) | [1.7](/filings/0001628280-26-026040.md) | [3.3](/filings/0001628280-26-049220.md) | [0.6](/filings/0001628280-26-066726.md) | [1.4 d](/filings/0001628280-26-006901.md) | [5.7](/filings/0001628280-26-026040.md) | [6.3](/filings/0001628280-26-049220.md) | [8.5](/filings/0001628280-26-066726.md) |
| Diluted EPS | $ per share | not reported | [0.01](/filings/0001798100-25-000077.md) | [(0.03)](/filings/0001798100-25-000096.md) | [(0.07)](/filings/0001628280-25-046456.md) | not reported | [0.02](/filings/0001628280-26-026040.md) | [0.04](/filings/0001628280-26-049220.md) | [0.01](/filings/0001628280-26-066726.md) | not reported | [0.06](/filings/0001628280-26-026040.md) | [0.06](/filings/0001628280-26-049220.md) | [0.08](/filings/0001628280-26-066726.md) |
| Basic EPS | $ per share | not reported | [0.01](/filings/0001798100-25-000077.md) | [(0.03)](/filings/0001798100-25-000096.md) | [(0.07)](/filings/0001628280-25-046456.md) | not reported | [0.02](/filings/0001628280-26-026040.md) | [0.04](/filings/0001628280-26-049220.md) | [0.01](/filings/0001628280-26-066726.md) | not reported | [0.06](/filings/0001628280-26-026040.md) | [0.06](/filings/0001628280-26-049220.md) | [0.08](/filings/0001628280-26-066726.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [1,946](/filings/0001798100-25-000039.md) | [2,026](/filings/0001798100-24-000058.md) | [2,098](/filings/0001798100-24-000065.md) | [2,185](/filings/0001798100-24-000080.md) | [2,259](/filings/0001628280-26-006901.md) | [2,285](/filings/0001798100-25-000077.md) | [2,312](/filings/0001798100-25-000096.md) | [2,468](/filings/0001628280-25-046456.md) | [2,614](/filings/0001628280-26-066726.md) | [2,810](/filings/0001628280-26-026040.md) | [3,036](/filings/0001628280-26-049220.md) | [3,280](/filings/0001628280-26-066726.md) |
| Total liabilities | $m | [673](/filings/0001798100-25-000039.md) | [756](/filings/0001798100-24-000058.md) | [780](/filings/0001798100-24-000065.md) | [838](/filings/0001798100-24-000080.md) | [921](/filings/0001628280-26-006901.md) | [972](/filings/0001798100-25-000077.md) | [988](/filings/0001798100-25-000096.md) | [1,162](/filings/0001628280-25-046456.md) | [1,162](/filings/0001628280-26-066726.md) | [1,298](/filings/0001628280-26-026040.md) | [1,457](/filings/0001628280-26-049220.md) | [1,271](/filings/0001628280-26-066726.md) |
| Long-term debt | $m | [608](/filings/0001798100-25-000039.md) | [703](/filings/0001798100-24-000058.md) | [726](/filings/0001798100-24-000065.md) | [779](/filings/0001798100-24-000080.md) | [868](/filings/0001628280-26-006901.md) | [913](/filings/0001798100-25-000077.md) | [927](/filings/0001798100-25-000096.md) | [1,097](/filings/0001628280-25-046456.md) | [1,095](/filings/0001628280-26-066726.md) | [1,234](/filings/0001628280-26-026040.md) | [1,396](/filings/0001628280-26-049220.md) | [1,191](/filings/0001628280-26-066726.md) |
| Shareholders' equity | $m | [1,265](/filings/0001798100-25-000039.md) | [1,261](/filings/0001798100-24-000058.md) | [1,310](/filings/0001798100-24-000065.md) | [1,340](/filings/0001798100-24-000080.md) | [1,331](/filings/0001628280-26-006901.md) | [1,306](/filings/0001798100-25-000077.md) | [1,317](/filings/0001798100-25-000096.md) | [1,299](/filings/0001628280-25-046456.md) | [1,446](/filings/0001628280-26-066726.md) | [1,505](/filings/0001628280-26-026040.md) | [1,572](/filings/0001628280-26-049220.md) | [2,003](/filings/0001628280-26-066726.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.6 d](/filings/0001628280-26-006901.md) | [11.7](/filings/0001798100-25-000077.md) | [25.4 d](/filings/0001798100-25-000096.md) | [25.1 d](/filings/0001628280-25-046456.md) | [28.0 d](/filings/0001628280-26-006901.md) | [22.1](/filings/0001628280-26-026040.md) | [30.6 d](/filings/0001628280-26-049220.md) | [28.0 d](/filings/0001628280-26-066726.md) | [28.8 d](/filings/0001628280-26-006901.md) | [26.3](/filings/0001628280-26-026040.md) | [36.7 d](/filings/0001628280-26-049220.md) | [41.8 d](/filings/0001628280-26-066726.md) |
| Dividends paid | $m | [14.1 d](/filings/0001628280-26-006901.md) | [15.0](/filings/0001798100-25-000077.md) | [15.0 d](/filings/0001798100-25-000096.md) | [16.3 d](/filings/0001628280-25-046456.md) | [17.1 d](/filings/0001628280-26-006901.md) | [17.2](/filings/0001628280-26-026040.md) | [17.2 d](/filings/0001628280-26-049220.md) | [17.9 d](/filings/0001628280-26-066726.md) | [18.0 d](/filings/0001628280-26-006901.md) | [21.4](/filings/0001628280-26-026040.md) | [21.4 d](/filings/0001628280-26-049220.md) | [22.9 d](/filings/0001628280-26-066726.md) |
| Share repurchases | $m | [0.2 d](/filings/0001628280-26-006901.md) | [1.1](/filings/0001798100-25-000077.md) | [0.2 d](/filings/0001798100-25-000096.md) | [0.1 d](/filings/0001628280-25-046456.md) | [0.2 d](/filings/0001628280-26-006901.md) | [0.6](/filings/0001628280-26-026040.md) | [0.1 d](/filings/0001628280-26-049220.md) | [0.1 d](/filings/0001628280-26-066726.md) | [0.0 d](/filings/0001628280-26-006901.md) | [1.7](/filings/0001628280-26-026040.md) | [0.1 d](/filings/0001628280-26-049220.md) | [0.1 d](/filings/0001628280-26-066726.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [58.9](/filings/0001798100-24-000058.md) | [61.0](/filings/0001798100-24-000065.md) | [68.0](/filings/0001798100-24-000080.md) | [74.6](/filings/0001798100-25-000077.md) | [73.6](/filings/0001798100-25-000096.md) | [77.6](/filings/0001628280-25-046456.md) | [82.1](/filings/0001628280-26-026040.md) | [82.5](/filings/0001628280-26-049220.md) | [85.6](/filings/0001628280-26-066726.md) | [99.1](/filings/0001628280-26-026040.md) | [103](/filings/0001628280-26-049220.md) | [108](/filings/0001628280-26-066726.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,632,968 at 2026-10-16, from the cover of the [10-Q filed 2026-10-21](/filings/0001628280-26-066726.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.